Your basket is currently empty!
Opdivo + Yervoy fails adjuvant phase 3 trial
Bristol-Myers Squibb has revealed that its checkpoint inhibitor combination of Opdivo and Yervoy failed a phase 3 ...
News Archive
Opdivo
Our work depends on donations from generous people so that we can support those affected by kidney cancer.
Would you like to support our work through a donation?
